Relion Novolin 70/30 Innolet Interactions
There are 393 drugs known to interact with Relion Novolin 70/30 Innolet (insulin isophane / insulin regular), along with 3 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 15 are major, 357 are moderate, and 21 are minor.
- View all 393 medications that may interact with Relion Novolin 70/30 Innolet
- View Relion Novolin 70/30 Innolet alcohol/food interactions (2)
- View Relion Novolin 70/30 Innolet disease interactions (3)
Most frequently checked interactions
View interaction reports for Relion Novolin 70 / 30 Innolet (insulin isophane / insulin regular) and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- acai
- Accupril (quinapril)
- acetaminophen
- acetaminophen / codeine
- Advair Diskus (fluticasone / salmeterol)
- albuterol
- alendronate
- allopurinol
- aloe vera
- Alpha-Lipoic-Acid-300 (alpha-lipoic acid)
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- carvedilol
- CoQ10 (ubiquinone)
- docusate
- Flexeril (cyclobenzaprine)
- furosemide
- gabapentin
- hydrocodone
- lisinopril
- metformin
- oxycodone
- pravastatin
- Relion Novolin N (insulin isophane)
- ReliOn/Novolin R (insulin regular)
- simvastatin
- spironolactone
- Vitamin D3 (cholecalciferol)
Relion Novolin 70/30 Innolet alcohol/food interactions
There are 2 alcohol/food interactions with Relion Novolin 70 / 30 Innolet (insulin isophane / insulin regular).
Relion Novolin 70/30 Innolet disease interactions
There are 3 disease interactions with Relion Novolin 70 / 30 Innolet (insulin isophane / insulin regular) which include:
More about Relion Novolin 70 / 30 Innolet (insulin isophane / insulin regular)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.